Sigmoidoscopy Reduces CRC Incidence Rates in Men in Norwegian Screening Study - Takeaways - MDSpire
Clinical Guidelines

Sigmoidoscopy Reduces CRC Incidence Rates in Men in Norwegian Screening Study

  • By

  • The ASCO Post Staff

  • May 15, 2026

  • 3 min

Share

  • 1

    NORCCAP trial assessed sigmoidoscopy screening efficacy.

  • 2

    Male participants showed a significant reduction in colorectal cancer risk.

  • 3

    Follow-up lasted 23 years post randomization.

  • 4

    Screening reduced related mortality in men by 0.8%.

  • 5

    Minimal impact of fecal blood testing on screening outcomes.

  • 6

    Results suggest fewer screenings could be adequate.

Original Source(s)

Related Content